Other lines
- Number of publications
- 580
Publications
-
Diaz-Gomez, J; Twyman, RM; Zhu, CF; Farre, G; Serrano, JCE; Portero-Otin, M; Muñoz, P.; Sandmann, G; Capell, T; Christou, P
Biofortification of crops with nutrients: factors affecting utilization and storage
Current Opinion In Biotechnology 44 115-123. .
-
Pifarre, M; Carrera, A; Vilaplana, J; Cuadrado, J; Solsona, S; Abella, F; Solsona, F; Alves, R
TControl: A mobile app to follow up tobacco-quitting patients
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE 142 81-89. .
-
Domingo, P; Sancho, F
Neisseria meningitidis and purpura fulminans in a woman with chronic liver disease
LANCET INFECTIOUS DISEASES 17 459-459. .
-
Huerva, V; Traveset, AE; Vilardell, F
Topical Interferon Alpha-2b for Diffuse Conjunctival Primary Acquired Melanosis with Atypia
Ocular Immunology And Inflammation 25 284-286. .
-
Cabezon, M.; Bargay, J.; Xicoy, B.; Garcia, O.; Tormo, M.; Palomo, L.; Marce, S.; Valcarcel, D.; Pedro, C.; Jimenez, M. J.; Borras, J.; Guardia, R.; Brunet, S.; Marti, J. M.; Garcia, A.; Zamora, L.
TP53 MUTATIONS IN HIGH RISK MYELODYSPLASTIC SYNDROMES PATIENTS TREATED WITH AZACITIDINE ACCORDING TO CETLAM GROUP PROTOCOL
LEUKEMIA RESEARCH 55 155-155. .
-
Redondo Guijo, A. M.; Sanchez-Barba, M.; Sanz Santillana, G.; Bernal, T.; Arnan Sangerman, M.; Ramos Ortega, F.; Pedro Olive, C.; Amigo Lozano, M. L.; Marco Betes, V.; Valcarcel, D.; Ardanaz, M.; Brunet, S.; Bargay Lleonart, J.; Tormo, M.; Xicoy, B.; Nomdedeu, M.; Lopez Cadenas, F.; Caballero Berrocal, J. C.; Canizo, M. C. D.; Diez-Campelo, M.
WHAT IS THE OUTCOME OF PATIENTS IN THE INTERMEDIATE IPSS-R SCORE GROUP? SPANISH APPROACH FOR BETTER STRATIFICATION WITH CLASSICAL TOOLS
LEUKEMIA RESEARCH 55 150-151. .
-
Arroyo D; Betriu A; Valls J; Gorriz JL; Pallares V; Abajo M; Gracia M; Valdivielso JM; Fernandez E
Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study
NEPHROLOGY DIALYSIS TRANSPLANTATION 32 513-520. .
-
Saumoy, M; Tiraboschi, JM; Ordoñez-Llanos J; Ribera, E; Domingo, P; Mallolas, J; Curto, J; Gatell, JM; Podzamczer, D
Atherogenic properties of LDL particles after switching from Truvada or Kivexa plus lopinavir/r to lamivudine plus lopinavir/r: OLE-MET substudy
HIV CLINICAL TRIALS 18 49-53. .
-
Negredo, E; Estrada, V; Domingo, P; Gutierrez, MD; Mateo, GM; Puig, J; Bonjoch, A; Ornelas, A; Echeverria, P; Estany, C; Toro, J; Clotet, B
Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 72 844-849. .
-
Gasol Cudos, A.; Morales Murillo, S.; Panades Siurana, M. J.; Vilardell Villellas, F.; Canosa Morales, C.; Mele Olive, J.; Iglesias Martinez, E.; Salud Salvia, A.
Change in treatment decisions according to Oncotype Dx Recurrence Score in node positive and negative, estrogen-receptor positive (ER+), HER2 negative breast cancer in a single institution
BREAST 32 92-93. .
-
Carlos Yebenes, Juan; Carlos Ruiz-Rodriguez, Juan; Ferrer, R; Cleries, M; Bosch, A; Lorencio, C; Rodriguez, A; Nuvials, X; Martin-Loeches, I; Artigas, A; SOCMIC Catalonian Critical Care
Epidemiology of sepsis in Catalonia: analysis of incidence and outcomes in a European setting
Annals of Intensive Care 7 19-19. .
-
Rivero, A; Perez-Molina, JA; Blasco, AJ; Arribas, JR; Crespo, M; Domingo, P; Estrada, V; Iribarren, JA; Knobel, H; Lazaro, P; Lopez-Aldeguer, J; Lozano, F; Moreno, S; Palacios, R; Pineda, JA; Pulido, F; Rubio, R; de la Torre, J; Tuset, M; Gatell, JM
Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 35 88-99. .
